Opsidio
Phase 2At OPSIDIO, we’re passionate about developing remedies for the millions of people affected by the damaging effects of chronic inflammation.Chronic inflammation stemming from diverse causes results in a numberof severe diseases, including organ fibrosis. We seek to control these diseases.
Founded
2022
Focus
AntibodiesBiologics
About
At OPSIDIO, we’re passionate about developing remedies for the millions of people affected by the damaging effects of chronic inflammation.Chronic inflammation stemming from diverse causes results in a numberof severe diseases, including organ fibrosis. We seek to control these diseases.
Company Info
TypePrivate
Founded2022
LocationBoston, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile